Skip to main content

Department of Transfusion Medicine

2018 DTM Symposiums

37th Annual Immunohematology & Blood Bank Symposium

William Ward speaking
Deputy Chief of the Department of Transfusion Medicine, William Ward, PhD moderates a session at the 9/11/2018 symposium.
 
Professor Karen King, Porter Siems (left) with their daughter Lily VK Siems (right)
On behalf of his wife, Professor Karen King, Porter Siems (left) with their daughter Lily VK Siems (right) accepts the Richard J. Davey Award from Dr. Paul M. Ness of Johns Hopkins Medical Institutions (center).
 
Chris Miskel speaking
Chris Miskel, president and CEO of Versiti participates in a discussion with the audience.
 

The NIH Clinical Center Department of Transfusion Medicine and the American Red Cross co-hosted the 37th annual Immunohematology & Blood Bank Symposium Sept. 11. Over 150 people gathered in Masur Auditorium to learn about recent developments, current practices, controversies and laboratory management issues relative to transfusion medicine.

Karen King, MD of Johns Hopkins Medical Institutions was awarded, posthumously, the Richard J. Davey Lectureship Award. This award recognizes an individual whose contributions have significantly advanced the field of transfusion medicine. Her husband Porter Siems received the award from Paul M. Ness, MD of Johns Hopkins Medical Institutions who gave a brief yet heart-felt tribute to Dr. King.

Topics discussed during the symposium included uses of group A plasma, storage temperature of platelets, red blood cell use in cardiac disease, and extracorporeal photopheresis. Three clinical vignettes were presented as well with focus on clinical practices and patient safety.

8th Annual Red Cell Genotyping Symposium

The NIH Clinical Center Department of Transfusion Medicine (DTM) with Versiti and its BloodCenter of Wisconsin, co-hosted the 8th annual Red Cell Genotyping Symposium Sept. 12 in the Natcher Auditorium. The symposium, titled "Patient Care", attracted more than 100 people and reviewed the risks of red cell alloimmunization and emerging applications of molecular matching to enhance patient safety. Dr. Willy Flegel, chief of the Laboratory Services Section of the DTM, served as one of the moderators and introduced Chris Miskel, president and CEO of Versiti, who discussed the current state of the U.S. blood supply. All topics presented were patient care focused and included several talks about strategies to avoid red cell alloimmunization and clinical vignettes to describe patient cases to illustrate patient care management utilizing genotyping results.

Gregory A. Denomme (left), Willy A. Flegel (right), and Sue Johnson, MSTM, MT(ASCP)SBB (center)
The scientific committee, Drs. Gregory A. Denomme (left) and Willy A. Flegel (right), and the symposium coordinator, Sue Johnson, MSTM, MT(ASCP)SBB (center) during the Red Cell Genotyping symposium.

NOTE: PDF documents require the free Adobe Reader.

This page last updated on 01/14/2019

You are now leaving the NIH Clinical Center website.

This external link is provided for your convenience to offer additional information. The NIH Clinical Center is not responsible for the availability, content or accuracy of this external site.

The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site’s privacy policy if you follow this link.

More information about the NIH Clinical Center Privacy and Disclaimer policy is available at http://www.cc.nih.gov/disclaimers.html